XBiotech (NASDAQ:XBIT) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report report published on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBIT opened at $4.00 on Friday. The stock has a market cap of $121.75 million, a P/E ratio of -3.36 and […]
More Stories
At Least 11 Injured in Stabbing Attack at Michigan Walmart
By T.J. Muscaro A stabbing incident at a Walmart in Traverse City, Michigan, left at least 11 people injured on...
New York Yankees’ Aaron Judge Headed to Injured List With Elbow Injury
By Ross Kelly The New York Yankees dropped their third straight game on Saturday, falling 9–4 to the Philadelphia Phillies....
Trump Secures Key Trade Agreements Ahead of Aug. 1—Here’s What to Know
By Andrew Moran President Donald Trump has announced a growing list of bilateral trade agreements ahead of the Aug. 1...
How to Delete a Threads Account? Step-by-Step Guide
Just like everyone, I was curious the first time Threads appeared. It was still being referred to as the Twitter...
Andraya Carter’s Wife, Career, Net Worth & Bre Austin Rumors
Andraya Carter has become a famous figure in sports. You might have spotted her on ESPN, or you can even...
Odds of US–EU Trade Deal Are 50–50 Ahead of Tariff Deadline: Trump
By Austin Alonzo President Donald Trump said there’s a 50–50 chance that the United States will finalize a trade deal...